Should I Buy PBI? PBI 2026 Analysis

Should You Buy Pitney Bowes Inc (PBI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

10.130

1 Day change

-0.39%

52 Week Range

13.110

Analysis Updated At

2026/01/26

Pitney Bowes Inc (PBI) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock is facing significant headwinds, including declining mailing volumes, weak financial performance, and bearish technical indicators. While there are no immediate positive catalysts or strong trading signals, the stock's valuation may be compelling for some investors seeking a speculative opportunity. However, given the user's preference for long-term growth and stability, holding off on this investment is recommended.

Technical Analysis

The technical indicators are bearish. The MACD is negative and expanding downward, RSI is neutral at 42.106, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at $10.088 and resistance at $10.733.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market, but the overall volume is relatively low, limiting its significance.

Technical Summary

Sell

Buy

Positive Catalysts

Pitney Bowes maintains a market leadership position in mailing and logistics, and analysts from Citizens JMP see potential in its shareholder-friendly capital allocation. Additionally, the gross margin increased slightly YoY, showing some operational efficiency.

Neutral/Negative Catalysts

Hedge funds are selling heavily, with a 713.33% increase in selling activity over the last quarter. The company's financial performance is weak, with revenue, net income, and EPS all declining significantly YoY. Analysts highlight risks from declining mailing volumes, and there are no recent news or event-driven catalysts to drive the stock upward.

Financial Performance

In Q3 2025, revenue dropped by 7.97% YoY to $459.68M. Net income fell drastically by 137.53% YoY to $51.96M, and EPS declined by 138.96% YoY to $0.30. However, gross margin improved slightly to 53.14%, up 1.51% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst ratings are mixed. Truist and Goldman Sachs have a Hold/Neutral rating with a price target of $11, reflecting a fairly valued stock. Citizens JMP has an Outperform rating with a $13 price target, citing compelling valuation and shareholder-friendly actions. However, analysts also highlight risks from declining mailing volumes and a flat earnings base into 2026.

3 Analyst Rating

Wall Street analysts forecast PBI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PBI is 11.14 USD with a low forecast of 9.43 USD and a high forecast of 13 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

Current: 10.170

Low

9.43

Averages

11.14

High

Current: 10.170

Low

9.43

Averages

11.14

High

Truist

Jasper Bibb

Hold

initiated

$11

AI Analysis

2025-12-12

Reason

Truist

Jasper Bibb

Price Target

$11

AI Analysis

2025-12-12

initiated

Hold

Reason

Truist analyst Jasper Bibb initiated coverage of Pitney Bowes with a Hold rating and $11 price target. The company's earnings base is "roughly flat" into fiscal 2026 and the stock's valuation fairly reflects its profile as a cash-generative business in a challenged end market, the analyst tells investors in a research note. The firm says Pitney Bowes faces headwinds from ongoing declines in mailing volumes, which creates risk to 2027 sales estimates.

Citizens JMP

Outperform

initiated

$13

2025-12-03

Reason

Citizens JMP

Price Target

$13

2025-12-03

initiated

Outperform

Reason

Citizens JMP initiated coverage of Pitney Bowes with an Outperform rating and $13 price target. The firm says Pitney is the dominant player for sending and first-mile sortation of physical mail in the U.S. The company Pitney enjoys a market leadership position in both of its business segments and the shares at current levels offer a "compelling" valuation, the analyst tells investors in a research note. Citizens believes Pitney's new management has been decisive with shareholder-friendly capital allocation actions.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for PBI

Unlock Now

PBI Should I Buy

PBI Should I Buy

Should You Buy Pitney Bowes Inc (PBI) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch